Australia Animal Drug Compounding Market Size & Outlook, 2030

Revenue, 2022 (US$M)

$27.1

Forecast, 2030 (US$M)

$59.7

CAGR, 2023 - 2030

10.4%

Report Coverage

Australia

Australia animal drug compounding market, 2018-2030 (US$M)

Global Animal Drug Compounding Industry Outlook

North America Animal Drug Compounding Market Outlook

U.S. Animal Drug Compounding Market Outlook

Canada Animal Drug Compounding Market Outlook

Europe Animal Drug Compounding Market Outlook

Germany Animal Drug Compounding Market Outlook

France Animal Drug Compounding Market Outlook

Italy Animal Drug Compounding Market Outlook

Spain Animal Drug Compounding Market Outlook

UK Animal Drug Compounding Market Outlook

Asia Pacific Animal Drug Compounding Market Outlook

Japan Animal Drug Compounding Market Outlook

China Animal Drug Compounding Market Outlook

India Animal Drug Compounding Market Outlook

South Korea Animal Drug Compounding Market Outlook

Latin America Animal Drug Compounding Market Outlook

Mexico Animal Drug Compounding Market Outlook

Brazil Animal Drug Compounding Market Outlook

MEA Animal Drug Compounding Market Outlook

South Africa Animal Drug Compounding Market Outlook

Saudi Arabia Animal Drug Compounding Market Outlook

The Australia animal drug compounding market generated a revenue of USD 27.1 million in 2022 and is expected to reach USD 59.7 million by 2030.
The Australia market is expected to grow at a CAGR of 10.4% from 2023 to 2030.
In terms of segment, oral was the largest revenue generating route of administration in 2022.
Topical is the most lucrative route of administration segment registering the fastest growth during the forecast period.

Market revenue in 2022	USD 27.1 million
Market revenue in 2030	USD 59.7 million
Growth rate	10.4% (CAGR from 2022 to 2030)
Largest segment	Oral
Fastest growing segment	Topical
Historical data	2018 - 2021
Base year	2022
Forecast period	2023 - 2030
Quantitative units	Revenue in USD million
Market segmentation	Oral, Injectable, Topical, Other Routes
Key market players worldwide	Partners Group Holding AG, Vimian Group AB, Pharmaca, Akina, Triangle Compounding Pharmacy, Central Compounding Pharmacy, Wellness Compounding Pharmacy, Miller Pharmacy

In terms of revenue, Australia accounted for 2.1% of the global animal drug compounding market in 2022.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
In Asia Pacific, China animal drug compounding market is projected to lead the regional market in terms of revenue in 2030.
India is the fastest growing regional market in Asia Pacific and is projected to reach USD 94.3 million by 2030.